ATRIA Bleeding Risk Score
The ATRIA Bleeding Risk Score estimates the risk of major hemorrhage in anticoagulated patients with atrial fibrillation based on anemia, renal disease, age ≥75, prior bleeding, and hypertension.
Indications for Use
Used to estimate warfarin‑associated major bleeding risk in adults with atrial fibrillation starting or receiving anticoagulation, mainly to identify modifiable bleeding factors, not to deny therapy. Derived and validated in 9,186 AF patients with 1.4%/yr major hemorrhage 1 [Level I evidence]. Predictive performance is modest and high specificity but low sensitivity compared with other scores 2 [Level II evidence].
Insights & Cautions
Incorporates age, anemia, severe CKD, prior bleeding, and hypertension to classify warfarin‑treated AF patients, but discriminates poorly and overestimates risk in high‑risk groups (c‑index ~0.58–0.59 in external cohorts) 1 [Level I evidence]. Developed for warfarin, not DOACs; less accurate than ORBIT or ABC‑bleeding for predicting major bleeding 2 [Level II evidence]. Should not be used to withhold anticoagulation; best used only to flag modifiable risks.